Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Amicus Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 272
- −13 vs. Q1 2025
- Shares held
- 319.5M
- +7.43M (+2.4%) vs. Q1 2025
- Total value
- $1.83B
- −$716.1M (−28.1%) vs. Q1 2025
- New holders
- 34
- 120 more added
- Sold out
- 47
- 82 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $11.5K |
| Q1 2026 | 298 | $4.81B |
| Q4 2025 | 332 | $4.57B |
| Q3 2025 | 287 | $2.46B |
| Q2 2025 | 272 | $1.83B |
| Q1 2025 | 286 | $2.55B |
| Q4 2024 | 290 | $2.88B |
| Q3 2024 | 293 | $3.31B |
| Q2 2024 | 259 | $3.13B |
| Q1 2024 | 254 | $3.79B |
| Q4 2023 | 229 | $4.53B |
| Q3 2023 | 229 | $3.63B |
| Q2 2023 | 216 | $3.86B |
| Q1 2023 | 226 | $3.30B |
| Q4 2022 | 230 | $3.57B |
| Q3 2022 | 222 | $3.05B |
| Q2 2022 | 213 | $3.28B |
| Q1 2022 | 216 | $2.87B |
| Q4 2021 | 224 | $3.48B |
| Q3 2021 | 238 | $2.80B |
| Q2 2021 | 235 | $2.67B |
| Q1 2021 | 259 | $2.74B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bryce Point Capital, LLC | 0 | $0 | 0.00% | −12,282−100.0% | Sold out |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −11,717−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,021−100.0% | Sold out |
| BI Asset Management Fondsmaeglerselskab A/S | 0 | $0 | 0.00% | −6,494−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −5,900−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,607−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,700−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −2,694−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,723−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,376−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −958−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −858−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −640−100.0% | Sold out |
| Aventura Private Wealth, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −220−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| South State Corp. | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Kodai Capital Management LP | – | – | – | – | Not filed |